Biostar Pharmaceuticals Incorporated (NASDAQ:BSPM) Sellers Covered 28.3% of Their Shorts

September 17, 2017 - By Ellis Scott

 Biostar Pharmaceuticals Incorporated (NASDAQ:BSPM) Sellers Covered 28.3% of Their Shorts

The stock of Biostar Pharmaceuticals Incorporated (NASDAQ:BSPM) registered a decrease of 28.3% in short interest. BSPM’s total short interest was 199,400 shares in September as published by FINRA. Its down 28.3% from 278,100 shares, reported previously. With 17,100 shares average volume, it will take short sellers 12 days to cover their BSPM’s short positions. The short interest to Biostar Pharmaceuticals Incorporated’s float is 9.09%.

The stock decreased 2.29% or $0.03 on September 15, reaching $1.28. About 6,810 shares traded. Biostar Pharmaceuticals Inc (NASDAQ:BSPM) has risen 57.27% since September 17, 2016 and is uptrending. It has outperformed by 40.57% the S&P500.

Biostar Pharmaceuticals, Inc. is a holding company. The company has market cap of $3.41 million. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, makes and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China). It currently has negative earnings. The Firm offers over-the-counter (OTC) products and prescription pharmaceuticals.

More notable recent Biostar Pharmaceuticals Inc (NASDAQ:BSPM) news were published by: Quotes.Wsj.com which released: “Biostar Pharmaceuticals Inc.” on February 11, 2011, also Marketwatch.com with their article: “1.28” published on December 27, 2010, Prnewswire.com published: “Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng …” on September 22, 2016. More interesting news about Biostar Pharmaceuticals Inc (NASDAQ:BSPM) were released by: Prnewswire.com and their article: “Biostar Pharmaceuticals, Inc. and Fmmu to Jointly Conduct Phases I To III …” published on June 13, 2012 as well as Prnewswire.com‘s news article titled: “Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic …” with publication date: September 18, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.